Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SAMHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PSMB8-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SP100 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLSCR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OASL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLRC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX60L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFIT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RSAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on